Trials / Completed
CompletedNCT01536353
Clinical Trial to Evaluate the Bioavailability and Safety of AGSAV301
A Single Dose, Randomized, Open-label, 2x2 Crossover Study to Evaluate the Bioavailability and Safety of AGSAV301 Tablet in Healthy Male Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Ahn-Gook Pharmaceuticals Co.,Ltd · Industry
- Sex
- Male
- Age
- 20 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate the bioavailability and safety of AGSAV301 tablet in healthy male volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | AGSAV301 | tablet, q.d. |
| DRUG | Exforge 10/160 | Tablet, q.d. |
Timeline
- Start date
- 2012-01-01
- Primary completion
- 2012-04-01
- Completion
- 2012-08-01
- First posted
- 2012-02-22
- Last updated
- 2015-11-25
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01536353. Inclusion in this directory is not an endorsement.